Biogen: “The Underperformance Stops Here”

Less than four months after warning investors to sell shares of Biogen, this analyst is easing back off his bearish stance. Here's why.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.